Latest News

Unconventional Weapon in the War on Cancer Revealed: Immunicom and Sheba Medical Center Initiate Clinical Trial to Evaluate Breakthrough Oncology Treatment, Immunopheresis Therapy

SAN DIEGO & TEL AVIV, Israel–(BUSINESS WIRE)–Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor. Sheba Medical Center, which is located in metro Tel Aviv, Israel, is the largest medical facility of its kind in the Middle East and was recently ranked as one of the top 10 Bes

Source link

Related posts

Medical News Today: Ketamine for depression: Study investigates side effects


NSU study points to another potential connection between sleep and overall good health


Well-capitalized insurtech Bright Health plans to double its footprint in 2020


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World